Latest News in the pharma Industry
Market News
.jpg)
Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19
16 Mar 2020
The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients.
Read more.jpg)
Contec launches virtual training tool sensitive to social distancing
16 Mar 2020
A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations.
Read more.jpg)
Mylan launches first bioequivalent alternative to Advair Diskus in Canada
10 Mar 2020
Appropriate asthma and COPD patients provided with a "more affordable alternative to appropriate".
Read more.jpg)
FDA approves Pharming's new facility for expanded Ruconest production
10 Mar 2020
Netherlands-based specialty pharmaceutical company Pharming has received US Food and Drug Administration (FDA) approval for its new biologics facility in the Netherlands which it says will ensure sufficient manufacturing capacity for its acute heredita...
Read more
Sartorius simplifies biologics production with new bioreactor
9 Mar 2020
Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.
Read more.jpg)
Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial
9 Mar 2020
Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.
Read more.jpg)
Nanoform and Orion collaborate on 'nanoformed' APIs
9 Mar 2020
Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.
Read more.jpg)
Bora Pharmaceuticals to buy GSK's Mississauga-based manufacturing facility
9 Mar 2020
CDMO Bora Pharmaceuticals said Monday it has agreed to acquire GlaxoSmithKline's Mississauga, Ontario (Canada) facility, which produces approximately 50 different products for more than 100 markets worldwide.
Read more.jpg)
Thermo Fisher Scientific to acquire Qiagen
3 Mar 2020
Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.
Read more.jpg)
Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven
3 Mar 2020
Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.
Read more.jpg)
MindMed becomes world's first psychedelic pharma company to go public
3 Mar 2020
The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.
Read more.jpg)
Jim Miller joins C2 Pharma advisory board
3 Mar 2020
Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, C2 Pharma, has expanded its advisory board with a new member.
Read more